Clinical Trial Update: SarCNU in Treating Patients With Recurrent Malignant Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SarCNU in patients with recurrent malignant glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Brain and Central Nervous System Tumors
• Malignant Glioma

Drugs mentioned

• SarCNU (sarCNU)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED